Column Group L P

Column Group L P serves as a Director and 10% Owner at NGM Biopharmaceuticals, Inc., a company focused on innovative therapies in the healthcare sector. The firm's recent trading activity, tracked through SEC Form 4 filings, shows a pattern of purchase activity between November 17, 2023, and April 8, 2024, with disclosed amounts ranging from $3.6K to $11.9K. Notably, the largest disclosed transaction was a purchase of approximately $11.9K on November 17, 2023, reflecting a consistent investment approach in NGM Biopharmaceuticals.